Inherited mutations in the SDH complex increase metastatic malignant potential of paragnglioma and phaeochromocytoma tumours
Bahram Jafar‐Mohammadi(King's College Hospital), Simon Aylwin(King's College Hospital NHS Foundation Trust), Barbara McGowan(Guy's and St Thomas' NHS Foundation Trust), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Paul Carroll(Guy's and St Thomas' NHS Foundation Trust), Salvador J. Díaz‐Cano(University Hospitals Birmingham NHS Foundation Trust), Ben Whitelaw, Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), Debashis Sarker(King's College - North Carolina), Klaus‐Martin Schulte(King's College Hospital)
Cited by 0
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters
|Annals of Surgery|2005|982
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
|Journal of Clinical Oncology|2013|833
Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety
|Endocrinology|2005|544